XML 90 R75.htm IDEA: XBRL DOCUMENT v3.23.1
Long-Term Investments (Details) - Schedule of extent the investee relies
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Braingenesis Biotechnology Co., Ltd. [Member]    
Long-Term Investments (Details) - Schedule of extent the investee relies [Line Items]    
Relationship with the Company and its subsidiaries, description No specific business relationship No specific business relationship
Genepharm Biotech Corporation [Member]    
Long-Term Investments (Details) - Schedule of extent the investee relies [Line Items]    
Relationship with the Company and its subsidiaries, description No specific business relationship No specific business relationship
BioHopeKing Corporation [Member]    
Long-Term Investments (Details) - Schedule of extent the investee relies [Line Items]    
Relationship with the Company and its subsidiaries, description Collaborating with the Company to develop and commercialize drugs Collaborating with the Company to develop and commercialize drugs
BioFirst Corporation [Member]    
Long-Term Investments (Details) - Schedule of extent the investee relies [Line Items]    
Relationship with the Company and its subsidiaries, description Loaned from investee and provides research and development support service Loaned from the investee and provides research and development support service
Rgene Corporation [Member]    
Long-Term Investments (Details) - Schedule of extent the investee relies [Line Items]    
Relationship with the Company and its subsidiaries, description Collaborating with the Company to develop and commercialize drugs Collaborating with the Company to develop and commercialize drugs